RAD50 and breast carcinoma: To further identify the synergies between INPP4B and RAD50 on clinical consequences at the genetic level, we are motivated to identify the relevant disease-associating SNPs that affect the expression of each gene and are collectively prognostic of the clinical outcome of breast cancer patients.